119 related articles for article (PubMed ID: 2437641)
41. Carbohydrate antigenic determinant (CA 19-9) and other tumor markers in gastrointestinal malignancies.
Yoshikawa T; Nishida K; Tanigawa M; Fukumoto K; Kondo M
Digestion; 1985; 31(2-3):67-76. PubMed ID: 2581838
[TBL] [Abstract][Full Text] [Related]
42. [A monoclonal antibody RIA as an antigenic determinant (CA 125) in ovarian cancer patients].
Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 1985 Sep; 20(5):257-60, 317. PubMed ID: 2417787
[No Abstract] [Full Text] [Related]
43. Selection of a monoclonal antibody reactive with a high-molecular-weight glycoprotein circulating in the body fluid of gastrointestinal cancer patients.
Sakurai Y; Hirohashi S; Shimosato Y; Kodaira S; Abe O
Cancer Res; 1988 Jul; 48(14):4053-8. PubMed ID: 2454734
[TBL] [Abstract][Full Text] [Related]
44. [Antigens associated with cancer of the pancreas].
Burtin P
Bull Cancer; 1990; 77(1):69-73. PubMed ID: 2317577
[TBL] [Abstract][Full Text] [Related]
45. [A radioimmunometric assay for circulating tumor-associated glycoprotein (TAG-72) using the antigen determinant CA 72-4].
Ohuchi N; Takahashi K; Matoba N; Mori S
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2761-6. PubMed ID: 2458074
[TBL] [Abstract][Full Text] [Related]
46. CAR-3, a monoclonal antibody-defined antigen expressed on human carcinomas.
Prat M; Morra I; Bussolati G; Comoglio PM
Cancer Res; 1985 Nov; 45(11 Pt 2):5799-807. PubMed ID: 2413998
[TBL] [Abstract][Full Text] [Related]
47. [Experience in the use of the tumor markers CEA, GICA and TPA in the postoperative monitoring of colorectal neoplasms].
Morelli M; Nardi M; Valle M; Balducci D; Serafini D; Bernardini P
Minerva Med; 1985 Sep; 76(34-35):1529-31. PubMed ID: 2412188
[TBL] [Abstract][Full Text] [Related]
48. [Serum levels and clinical evaluation of CA 19-9 in various diseases].
Toyama K; Noto M; Sakaguchi T; Adachi K; Mitomi H; Okada N; Ootaka H; Nakazawa H; Hara E
Gan No Rinsho; 1985 Mar; 31(3):293-8. PubMed ID: 2582158
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemistry of human gastrointestinal cancer-associated antigen detected by monoclonal antibody PA 8-15.
Yoshimura R; Sakamoto K; Egami H; Akagi M
Jpn J Cancer Res; 1988 Feb; 79(2):255-63. PubMed ID: 3130361
[TBL] [Abstract][Full Text] [Related]
50. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.
Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T
Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145
[TBL] [Abstract][Full Text] [Related]
51. [The tumor markers CA 19.9, Ca 50 and CEA in the differential diagnosis of pancreatic carcinoma].
Röthlin M; Metzger U; Joller H; Largiadèr F
Schweiz Med Wochenschr; 1988 Jun; 118(24):924-9. PubMed ID: 2456610
[TBL] [Abstract][Full Text] [Related]
52. [Immunohistochemical demonstration of CA 125, CA 19-9 and CEA in normal and pathologically changed adnexa].
Neunteufel W; Breitenecker G
Geburtshilfe Frauenheilkd; 1988 May; 48(5):334-7. PubMed ID: 3165079
[TBL] [Abstract][Full Text] [Related]
53. Measurement of a pancreatic cancer-associated antigen (DU-PAN-2) detected by a monoclonal antibody in sera of patients with digestive cancers.
Sawabu N; Toya D; Takemori Y; Hattori N; Fukui M
Int J Cancer; 1986 May; 37(5):693-6. PubMed ID: 3457770
[TBL] [Abstract][Full Text] [Related]
54. [Usefulness of the determination of CEA and Ca 19-9 in the diagnosis and staging of bronchial carcinoma].
Rapellino M; Pecchio F; Baldi S; Obert R; Bevilacqua Rapellino A; Libertucci D; Coni F; Oliaro A
Minerva Med; 1987 Mar; 78(6):373-5. PubMed ID: 3470632
[TBL] [Abstract][Full Text] [Related]
55. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity.
Thor A; Muraro R; Gorstein F; Ohuchi N; Viglione M; Szpak CA; Johnston WW; Schlom J
Cancer Res; 1987 Jan; 47(2):505-12. PubMed ID: 2431771
[TBL] [Abstract][Full Text] [Related]
56. [Diagnostic value of CA 19-9 and CEA in gastrointestinal pathology].
Patai A; Héber S; Döbrönte Z; Kovács LG
Orv Hetil; 1992 May; 133(21):1301-4, 1307. PubMed ID: 1603581
[TBL] [Abstract][Full Text] [Related]
57. Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker.
Bray KR; Koda JE; Gaur PK
Cancer Res; 1987 Nov; 47(22):5853-60. PubMed ID: 2444335
[TBL] [Abstract][Full Text] [Related]
58. [Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis].
Heptner G; Domschke S; Krapf F; Schneider MU; Iro H; Domschke W
Dtsch Med Wochenschr; 1984 Aug; 109(35):1309-12. PubMed ID: 6590287
[TBL] [Abstract][Full Text] [Related]
59. Tumor antigen CA 125 as a marker of ovarian epithelial carcinoma.
Zanaboni F; Vergadoro F; Presti M; Gallotti P; Lombardi F; Bolis G
Gynecol Oncol; 1987 Sep; 28(1):61-7. PubMed ID: 2443433
[TBL] [Abstract][Full Text] [Related]
60. [New prospects in the combined use of tumor markers in epithelial neoplasms of the ovary].
Indraccolo SR; Cecchi A; Thodos A; Brandi S; Carta G
Ann Ostet Ginecol Med Perinat; 1991; 112(1):36-40. PubMed ID: 1929097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
